Companies: 10,795·Total market cap: $144.5T
Sinopharm Group Co. Ltd.

Sinopharm Group Co. Ltd.

SHTDFOTCHealthcare● Active
$2.30
+$0.01(+0.44%)
Market Cap$7.2B
P/E Ratio—
52W High$2.7
52W Low$2.11
Cash on HandFinancialsRevenue

Sinopharm Group Co. Ltd. (SHTDF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

SHTDF · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$61.59B▲ +13.4% vs prior year
FY · as of Dec 31, 2025 · Reported in CNY
Cash & Cash Equiv. (CCE)
$61.59B
cashAndCashEquivalents
Short-Term Investments
$129,000
shortTermInvestments
YoY Change vs Prior Year
+13.4%
vs prior fiscal year
Latest Quarter
$61.59B
Q4 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in CNY

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$61.59BCash on Hand
Total Debt$108.64BTotal Debt
Net Cash / Net Debt−$47.04BNet Debt Position
Cash vs Debt Ratio
Cash 36%Debt 64%

Sinopharm Group Co. Ltd. carries a net debt position of $47.04B. Total debt ($108.64B) exceeds cash on hand ($61.59B). Sinopharm Group Co. Ltd. cash vs debt ratio: 36% cash / 64% debt.

Net Cash = Cash & ST Investments − Total Debt$61.59B − $108.64B = −$47.04B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
SHTDF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$61.59B+13.4%
Dec 31, 2024$54.31B-14.9%
Dec 31, 2023$63.81B+15.5%
Dec 31, 2022$55.22B+26.8%
Dec 31, 2021$43.54B-13.3%
SHTDF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
Sinopharm Group Co. Ltd.
Sinopharm Group Co. Ltd.YOU
SHTDF
$61.59B858.1%
#2
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#3
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#4
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Sinopharm Group Co. Ltd. (SHTDF) cash on hand as of December 31, 2025 is $61.59B, comprising $61.59B in cash and cash equivalents (CCE) plus $129,000 in short-term investments — reported as Sinopharm Group Co. Ltd. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Sinopharm Group Co. Ltd. cash reserves or cash position.

Sinopharm Group Co. Ltd. annual cash on hand history shows increased +13.4% in 2025: increased +13.4% in 2025. Sinopharm Group Co. Ltd. cash reserves in 2025 reflect the company's capital allocation strategy.

Sinopharm Group Co. Ltd. carries total debt of $108.64B against cash of $61.59B, resulting in a net debt position of -$47.04B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

SHTDF cash on hand · 5 questions

As of December 31, 2025, Sinopharm Group Co. Ltd. (SHTDF) has $61.59B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $61.59B in cash and cash equivalents (CCE) plus $129,000 in short-term investments. Latest quarter (December 31, 2025): $61.59B. Data sourced from the annual 10-K filing via FMP.

SHTDF cash on handSHTDF cash reservesSHTDF cash 2025how much cash does SHTDF have

▸ Source: FMP /balance-sheet-statement · US GAAP · Sinopharm Group Co. Ltd. · Sinopharm Group Co. Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025